get a key
steadybase-$ person John (CEO)
nameJohn (CEO)
roleCEO
company BIOL BIOL
linkedin none on file
contactnot published
filingsnone on file
quotes
This increase was due to commission expenses for achieving sales targets and travel-related expenses, and they were partially offset by a decrease in general and administrative expenses from compensation and severance, as well as decreased legal and consulting expenses incurred by engineering and development in the first quarter of 2022.

May 12, 2022 / CEO / receipt, needs a key / John (CEO), CEO | earnings call 2022-05-12 | transcript 291dbcc3-17bb-4822-b5cd-a9a190535a60 | chars 13800-14139 | segment 14

steadybase-$